Implant Veterans of Toxic Exposure

American Medical Technology-2

Home
Action
Alerts
Hayes
Congressional Report
AMT-1
AMT Audit
Fly-In
ASPRS Survey
Bell & Pointer
BI Capsules
BI Chemicals
BI Numbers - Dow
Burson-Marsteller
B-M's Spokesdoctors
Dr. Pierre Blais
Burson - NEW
Cab-O-Sil
CANDO
Capsules
Chemical Adverse
ChemBMS
Children
Chem Soup
Connie Chung
CRS_safety
Dowknew1
Dowknew2
Dowknew3
Dowknew4
Dow Bleed
Dow Disease
Dow Fraud
Dow Migration
Dow Rupture
DC Whines
Dr. Anderson
Explant
Gagged
Gel Reaction
Griffin Bell
Hancock
Harvard-Brigham
HAD
Inflammation
Jenny
Judge Jones Transcript
Kessler
Latissimus
Maryland Informed
McKennon
McGhan-Shells
Poem to Congress
No Evidence
Cole
Norman Cole
Notable People
Scleroderma
SS
Study-Adjuvant
Study-Adjuvant-FDA
Study-Beagle
Study-Dogs
Study NY
Study-Tissue Reaction
Talcott
Testimony
Ultra Sound
Links

American Medical Technology Audit Report 

Dow Corning's Inspector's report/audit of AMT did not agree with the a previous inspection by the FDA.

November 27, 1990                            DOW CORNING PROPRIETARY
 
To:           Ron Dieck            Dow Corning Wright
                Arnold Lawing       Dow Corning Wright
                Frank Lewis          Dow Corning Wright
 
CC:            George Picha, MD    Applied Medical Technology
 
From:        Les Schnoll            193
 
SUBJECT:    GOOD MANUFACTURING PRACTICES AUDIT AND SANITATION COMPLIANCE AUDIT APPLIED MEDICAL TECHNOLOGY, INC.
 
Attached for your information and review are the copies of the Good Manufacturing Practices Audit and Sanitaiton Compliance Audit where were performed at the Applied Medical Technology, Inc. (AMT) facilities in Independence, Ohio on November 19, 1990.  The audits were designed and conducted to determine the compliance with the Good Manufacturing, Packing, Storage, and Installation of Medical Devices (Title 21 of the Code of Federal Regulations, Part 820).  Moreover, the audit was conducted under the requirements for "critical" devices and components.  According to AMT personnel, the plant has also been audited by the United States Food and Drug Administration in June of 1990.
 
Applied Medical Technology, Inc. is located in several "storefronts" in a retail strip center on Brecksville Road in Independence, Ohio.  AMT currently manufactures and packages a line of microvascular instruments for Dow Corning Wrighte; contract sterilization is performed for AMT by Ethox Corporation (located in Buffalo, New York).  A current contract between AMT and Ethox is in place and appropriate sterilization validation documentation has been prepared by Ethox for those products.  AMT ownership is classified as private (George Picha, M.D.).  Personnel of AMT contacted during the audit included Ms. Pat Gilpin, Mr. Dean Secrest, and Mr. Richard Szczepinski.  All of those individuals report to General Manager (Mr. Gary Pond), who reports to Dr. Picha.  Approximately 50% of the work performed by AMT is classified as commercial; the remaining 50% is classified as proprietary.  Until approximately May of 1990, the company was known as Gastrotech, Inc. The company is currently registered with the United States Food and Drug Administration as Applied Medical Technology, Inc.; the establishement registration number for AMT is 1526012.
 
The facility has not developed any specific "Good Manufacturing Practices Compliance Manual," but "follows" the 4th edition (November 1987) of the Devica Good Manufacturing Practices Manual published by the United States Department of Health and Human Services.  This manual, therefore, becomes their Good Manufacturing Practices Compliance Manual, requiring compliance with all provisions identified therein.
 
Overall the results suggests passable level of compliance with the Good Manufacturing Practices for Medical Devices (indicating the likelihood of a Regulatory Letter being issued by the Agency) and an excellent of compliance with sanitation standards.  Documentation and adherence to procedures, as well as lack of procedures to address complaince with varioius provisions of the regulations, were determined to be the most significant areas of noncompliance.
 
The overall recommendation of this auditor relative to products currently manufactured and packaged for Dow Corning Wright is that conditional approval be granted, pending documented corrective action of all deficiences identified during this audit.  A written response should be submitted to Dow Corning Wright by January 15, 1991; such response should indicate corrective actions and timing.
 
 
 
 
 
 
 
 
 
 
 
 

Site maintained by Pamela G. Dowd